587 F.Supp.3d 641
M.D. Tenn.2022Background
- Clover Health (formerly Social Capital Hedosophia III) was taken public by a SPAC merger; defendants touted the internally developed "Clover Assistant" as central to Clover’s growth and competitive advantage.
- Plaintiffs allege Clover’s growth was actually driven by unlawful inducements (gift cards, paid "ambassadors") and undisclosed related‑party broker relationships (Head of Sales Hiram Bermudez), not the Assistant.
- The DOJ opened an investigation into possible kickbacks/False Claims Act issues; a CID was served on a former employee and the company received a DOJ request for information.
- Hindenburg Research published a short‑seller report revealing alleged problems (low Assistant adoption, inducements, related‑party dealings, DOJ inquiry), and Clover stock dropped after publication.
- Plaintiffs (consolidated, led by Jabri) filed an amended §10(b)/Rule 10b‑5 and §20(a) securities complaint; defendants moved to dismiss.
- The district court denied the motion, finding the amended complaint sufficiently pleaded falsity, materiality, scienter, and loss causation at the Rule 12(b)(6) stage.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Falsity/materiality of tech claims (Clover Assistant drove growth) | Statements that Assistant drove growth were false—Assistant was rarely used as represented and did not cause organic growth. | Statements were puffery or truthful/ambiguous; usage metrics reflected definitional choices, not fraud. | Court: Plaintiffs pleaded particularized facts that Assistant claims were materially misleading given context and corroborating CWs/Hindenburg. |
| Duty to disclose DOJ inquiry and AKS exposure | Failure to disclose a material DOJ investigation and illegal inducement practices rendered public compliance assurances false. | Routine government inquiries are not per se disclosable; requests were voluntary and not proof of material investigation. | Court: Allegations supported that the inquiry was material and that nondisclosure was misleading at pleading stage. |
| GAAP / related‑party disclosures (Bermudez/B&H) | Plaintiffs allege omission of material related‑party transactions that should have been disclosed under GAAP/Reg S‑X. | Disclosures were adequate; alleged related‑party ties were immaterial or speculative. | Court: Pleading was sufficient to raise plausible GAAP/related‑party nondisclosure claims. |
| Scienter and loss causation | Defendants knew or recklessly disregarded problems (due diligence, internal red flags, admitted awareness of DOJ inquiry); Hindenburg was corrective disclosure causing price drop. | Plaintiffs fail to plead strong inference of scienter; Hindenburg is not an adequate corrective disclosure for some alleged misconduct. | Court: Holistic reading yields a strong inference of scienter as to company and individual defendants; Hindenburg adequately pleaded as corrective disclosure and loss causation. |
Key Cases Cited
- Basic Inc. v. Levinson, 485 U.S. 224 (Sup. Ct. 1988) (establishes fraud‑on‑the‑market presumption of reliance).
- Tellabs, Inc. v. Makor Issues & Rights, Ltd., 551 U.S. 308 (2007) (governs PSLRA "strong inference" scienter standard and holistic review).
- Ashcroft v. Iqbal, 556 U.S. 662 (2009) (pleading standard for plausibility under Rule 8).
- Bell Atl. Corp. v. Twombly, 550 U.S. 544 (2007) (Twombly pleading‑standard principles).
- In re Omnicare, Inc. Sec. Litig., 769 F.3d 455 (6th Cir. 2014) (discusses opinion statements, materiality, and scienter analysis).
- Doshi v. Gen. Cable Corp., 823 F.3d 1032 (6th Cir. 2016) (confidential witness pleading sufficiency and scienter discussion).
- Ashland, Inc. v. Oppenheimer & Co., 648 F.3d 461 (6th Cir. 2011) (elements of §10(b) claim and materiality analysis).